1.
Novin K, Mortazavi N. Methodological Consideration for Clinical Development of Bevacizumab Biosimilar Candidate. Reports-of-Radiotherapy-and-Onco [Internet]. 17Mar.2019 [cited 18Dec.2025];5(1):1-. Available from: http://waocp.com/journal/index.php/Reports-of-Radiotherapy-and-Onco/article/view/2319